Metformin and CoQ10 combination therapy: a novel approach to mitigating ischemia-reperfusion injury and cognitive impairment
Co-administration of MT and CQ offered enhanced neuroprotection compared to individual treatments. This benefit may stem from additive or synergistic antioxidant effects and AMPK activation, suggesting potential for combined therapy in ischemic stroke management.
Authors
- Chandrashekhar Upasani (ORCID: https://orcid.org/0000-0003-4446-1557)
- Vipin Dhote (ORCID: https://orcid.org/0000-0003-3880-5616)
- Aman B. Upaganlawar (ORCID: https://orcid.org/0000-0003-4122-5081)
- Avinash Singh Mandloi
- Vivek Kumar Sinha
Institutions
- SCMS Group of Educational Institutions (IN)
- Savitribai Phule Pune University (IN)
Publication Details
- Journal
- Brain Injury
- Published
- 2026-01-06
- DOI
- https://doi.org/10.1080/02699052.2025.2612032
- Primary Topic
- Coenzyme Q10 studies and effects
- Type
- article
- Field-Weighted Citation Impact
- 0.00